Skip to Main Content

Author Details

Joel E Michalek
University of Texas Health Science Center
1982
223
48
PMIDPaper TitleJournal TitlePublished Year
37093199Phase II Investigation of TVB-2640 (Denifanstat) with Bevacizumab in Patients with First Relapse High-Grade Astrocytoma.Clin Cancer Res2023
37605355A Survey of Attitudes and Training of Pediatric Dentistry Residents and Faculty in the United States Regarding the LGBTQ Patient Population.Pediatr Dent2023
37659081AXL-initiated paracrine activation of pSTAT3 enhances mesenchymal and vasculogenic supportive features of tumor-associated macrophages.Cell Rep2023
37658148Non-chemotherapy adjuvant agents in TP53 mutant Ewing sarcoma.Sci Rep2023
37639818Rapid gastric emptying during pregnancy in a rat model.Eur J Obstet Gynecol Reprod Biol2023
37861386Correction: Utilizing metformin to prevent metabolic syndrome due to androgen deprivation therapy (ADT): a randomized phase II study of metformin in non-diabetic men initiating ADT for advanced prostate cancer.Oncotarget2023
37093199Phase II Investigation of TVB-2640 (Denifanstat) with Bevacizumab in Patients with First Relapse High-Grade Astrocytoma.Clin Cancer Res2023
37399144Pediatric ERCP: Factors for Success and Complication-A 17-Year, Multisite Experience.J Pediatr Gastroenterol Nutr2023
37335291Utilizing metformin to prevent metabolic syndrome due to androgen deprivation therapy (ADT): a randomized phase II study of metformin in non-diabetic men initiating ADT for advanced prostate cancer.Oncotarget2023
37861386Correction: Utilizing metformin to prevent metabolic syndrome due to androgen deprivation therapy (ADT): a randomized phase II study of metformin in non-diabetic men initiating ADT for advanced prostate cancer.Oncotarget2023
37659081AXL-initiated paracrine activation of pSTAT3 enhances mesenchymal and vasculogenic supportive features of tumor-associated macrophages.Cell Rep2023
37658148Non-chemotherapy adjuvant agents in TP53 mutant Ewing sarcoma.Sci Rep2023
37605355A Survey of Attitudes and Training of Pediatric Dentistry Residents and Faculty in the United States Regarding the LGBTQ Patient Population.Pediatr Dent2023
37639818Rapid gastric emptying during pregnancy in a rat model.Eur J Obstet Gynecol Reprod Biol2023
37335291Utilizing metformin to prevent metabolic syndrome due to androgen deprivation therapy (ADT): a randomized phase II study of metformin in non-diabetic men initiating ADT for advanced prostate cancer.Oncotarget2023
37399144Pediatric ERCP: Factors for Success and Complication-A 17-Year, Multisite Experience.J Pediatr Gastroenterol Nutr2023
34693628Bromodomain 4 inhibition leads to MYCN downregulation in Wilms tumor.Pediatr Blood Cancer2022
35506713Determination of safe levels of persistent organic pollutants in toxicology and epidemiology.Rev Environ Health2022
35820279Sensitization of osteosarcoma to irradiation by targeting nuclear FGFR1.Biochem Biophys Res Commun2022
35570846Plexin-B2 and Semaphorins Do Not Drive Rhabdomyosarcoma Proliferation or Migration.Sarcoma2022
35500278Enhanced Recovery Pathway Reduces Hospital Stay and Opioid Use in Microsurgical Breast Reconstruction: A Single-Center, Private Practice Experience.Plast Reconstr Surg2022
35739299Modulation of autophagy: a Phase II study of vorinostat plus hydroxychloroquine versus regorafenib in chemotherapy-refractory metastatic colorectal cancer (mCRC).Br J Cancer2022
35797217Regulation of TORC1 by MAPK Signaling Determines Sensitivity and Acquired Resistance to Trametinib in Pediatric BRAFV600E Brain Tumor Models.Clin Cancer Res2022
36474708The effect of continuous positive airway pressure on inferior vena cava collapsibility as measured by bedside ultrasound.J Am Coll Emerg Physicians Open2022
36660468Expanding the Use of Endoscopic Retrograde Cholangiopancreatography in Pediatrics: A National Database Analysis of Demographics and Complication Rates.Gastroenterology Res2022
35245253Prospective Longitudinal Patient-Reported Satisfaction and Health-Related Quality of Life following DIEP Flap Breast Reconstruction: Effects of Reconstruction Timing.Plast Reconstr Surg2022
35094009SMARCA4 biology in alveolar rhabdomyosarcoma.Oncogene2022
34693628Bromodomain 4 inhibition leads to MYCN downregulation in Wilms tumor.Pediatr Blood Cancer2022
35739299Modulation of autophagy: a Phase II study of vorinostat plus hydroxychloroquine versus regorafenib in chemotherapy-refractory metastatic colorectal cancer (mCRC).Br J Cancer2022
35506713Determination of safe levels of persistent organic pollutants in toxicology and epidemiology.Rev Environ Health2022
35797217Regulation of TORC1 by MAPK Signaling Determines Sensitivity and Acquired Resistance to Trametinib in Pediatric BRAFV600E Brain Tumor Models.Clin Cancer Res2022
35500278Enhanced Recovery Pathway Reduces Hospital Stay and Opioid Use in Microsurgical Breast Reconstruction: A Single-Center, Private Practice Experience.Plast Reconstr Surg2022
35570846Plexin-B2 and Semaphorins Do Not Drive Rhabdomyosarcoma Proliferation or Migration.Sarcoma2022
35820279Sensitization of osteosarcoma to irradiation by targeting nuclear FGFR1.Biochem Biophys Res Commun2022
36474708The effect of continuous positive airway pressure on inferior vena cava collapsibility as measured by bedside ultrasound.J Am Coll Emerg Physicians Open2022
36660468Expanding the Use of Endoscopic Retrograde Cholangiopancreatography in Pediatrics: A National Database Analysis of Demographics and Complication Rates.Gastroenterology Res2022
35094009SMARCA4 biology in alveolar rhabdomyosarcoma.Oncogene2022
35245253Prospective Longitudinal Patient-Reported Satisfaction and Health-Related Quality of Life following DIEP Flap Breast Reconstruction: Effects of Reconstruction Timing.Plast Reconstr Surg2022
33051659Genotype-Phenotype Features of Germline Variants of the TMEM127 Pheochromocytoma Susceptibility Gene: A 10-Year Update.J Clin Endocrinol Metab2021
34013206Receptor-driven invasion profiles in diffuse intrinsic pontine glioma.Neurooncol Adv2021
33853867Interleukin-4 Receptor Inhibition Targeting Metastasis Independent of Macrophages.Mol Cancer Ther2021
33828310Assessment of tumor hypoxia and perfusion in recurrent glioblastoma following bevacizumab failure using MRI and <sup>18</sup>F-FMISO PET.Sci Rep2021
33504881Phase 2 trial of hypoxia activated evofosfamide (TH302) for treatment of recurrent bevacizumab-refractory glioblastoma.Sci Rep2021
33051659Genotype-Phenotype Features of Germline Variants of the TMEM127 Pheochromocytoma Susceptibility Gene: A 10-Year Update.J Clin Endocrinol Metab2021
34796206Coding Variation and Adherence to Methodological Standards in Cardiac Research Using the National Inpatient Sample.Front Cardiovasc Med2021
34621937A Randomized Feasibility Trial Comparing Surveillance Regimens for Patients with Low and Low-Intermediate Risk Non-Muscle Invasive Bladder Cancer.Bladder Cancer2021
34432682Case Volume-Dependent Changes in Operative Morbidity following Free Flap Breast Reconstruction: A 15-Year Single-Center Analysis.Plast Reconstr Surg2021
35098099PEGylated talazoparib enhances therapeutic window of its combination with temozolomide in Ewing sarcoma.iScience2021
34532089Clinicopathologic differences and mortality among Latinos and non-Latino whites with gastric cancer at a majority-minority cancer center in South Texas.J Gastrointest Oncol2021
33828310Assessment of tumor hypoxia and perfusion in recurrent glioblastoma following bevacizumab failure using MRI and <sup>18</sup>F-FMISO PET.Sci Rep2021
  • 1 - 50 of 446

Recommended Authors

Mayo Clinic
Career Start Year 2004
Number of shared co-authors 2
The University of Oklahoma Health Sciences Center
Career Start Year 1999
Number of shared co-authors 1
Massachusetts General Hospital.
Career Start Year 1997
Number of shared co-authors 3
David Geffen School of Medicine at University of California los angeles
Career Start Year 1997
Number of shared co-authors 0
Icahn School of Medicine at Mount Sinai
Career Start Year 1995
Number of shared co-authors 0
Burn Research Center, Iran University of Medical Sciences
Career Start Year 1992
Number of shared co-authors 1
Robert H Lurie Comprehensive Cancer Center of Northwestern University
Career Start Year 1991
Number of shared co-authors 1
Vanderbilt University Medical Center
Career Start Year 1990
Number of shared co-authors 0
Marshfield Clinic Research Institute
Career Start Year 1989
Number of shared co-authors 0
Rutgers University School of Public Health
Career Start Year 1988
Number of shared co-authors 0
St Jude Children's Research Hospital.
Career Start Year 1988
Number of shared co-authors 10
Mayo Clinic
Career Start Year 1986
Number of shared co-authors 1
Perelman School of Medicine at the University of Pennsylvania
Career Start Year 1985
Number of shared co-authors 1
Cincinnati Children's Hospital Medical Center
Career Start Year 1985
Number of shared co-authors 0
and Clinical Center, Central Arkansas Veterans Healthcare System
Career Start Year 1984
Number of shared co-authors 2
Rollins School of Public Health, Emory University School of Medicine
Career Start Year 1984
Number of shared co-authors 0
Westmead Hospital
Career Start Year 1983
Number of shared co-authors 3
Massachusetts General Hospital
Career Start Year 1982
Number of shared co-authors 1
1Emory University
Career Start Year 1980
Number of shared co-authors 0
Defense Health Administration and US Army Institute of Surgical Research
Career Start Year 1980
Number of shared co-authors 5
Mass General Hospital
Career Start Year 1977
Number of shared co-authors 3
Harvard T.H. Chan School of Public Health
Career Start Year 1975
Number of shared co-authors 0
NYU Grossman School of Medicine
Career Start Year 1974
Number of shared co-authors 1
Weizmann Institute of Science
Career Start Year 1974
Number of shared co-authors 0
Brigham and Women's Hospital, Harvard Medical School
Career Start Year 1972
Number of shared co-authors 1
Health Informatics Institute, University of South Florida
Career Start Year 1971
Number of shared co-authors 1
Center for Andrology and Sexual Medicine, Viet Duc University Hospital
Career Start Year 1970
Number of shared co-authors 0
Center for Pharmacoepidemiology and Treatment Science, Rutgers University
Career Start Year 1970
Number of shared co-authors 0
School of Public Health, University of Alabama at Birmingham
Career Start Year 1963
Number of shared co-authors 0

Collaborators

Children's Cancer Therapy Development Institute
Co-authored papers 29
Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic
Co-authored papers 15
Oregon Health & Science University
Co-authored papers 14
University of Texas Health Science Center
Co-authored papers 13
University of Cambridge
Co-authored papers 12
University of Texas Health San Antonio
Co-authored papers 10
Co-authored papers 10
Children's Cancer Therapy Development Institute
Co-authored papers 9
Oregon Health & Science University
Co-authored papers 8
Institute for Frontier Medical Sciences, Kyoto University
Co-authored papers 6
Co-authored papers 6
Co-authored papers 6
Texas Tech University
Co-authored papers 6
University of Colorado Anschutz Medical Campus
Co-authored papers 6
Co-authored papers 5
Kyoto Prefectural University of Medicine
Co-authored papers 4
The University of Texas Health Science Center at San Antonio
Co-authored papers 4
Children's Cancer Therapy Development Institute
Co-authored papers 4
University of Pittsburgh Medical Center
Co-authored papers 3
University of Michigan ann arbor
Co-authored papers 3
Co-authored papers 3
University of Pittsburgh Medical Center
Co-authored papers 3
University of Virginia Department of Pathology
Co-authored papers 3
Kaohsiung Medical University
Co-authored papers 3
Joslin Diabetes Center
Co-authored papers 3
Co-authored papers 3
Pittsburgh University
Co-authored papers 3
University Medical Center Freiburg, University of Freiburg
Co-authored papers 3
University of Texas Health Science Center at San Antonio
Co-authored papers 3
Harborview Medical Center
Co-authored papers 3